Insulin Dose for Hyperkalemia
The recommended dose is 10 units of regular insulin IV with 25 grams of glucose (50 mL of D50W) over 15-30 minutes for adults, which effectively lowers potassium by approximately 0.8 mmol/L within 60 minutes. 1
Standard Adult Dosing Protocol
- Administer 10 units of regular insulin IV as the standard dose for hyperkalemia treatment 1
- Give with 25 grams of glucose (50 mL of D50W) over 15-30 minutes 1
- The insulin-to-glucose ratio is 1 unit of insulin for every 2.5 grams of glucose 1
- This regimen produces a mean potassium reduction of 0.78-0.79 mmol/L at 60 minutes 2
Higher Dose Regimen for Severe Cases
- For severe hyperkalemia (K+ >6.5 mEq/L) or marked ECG changes, consider 20 units of regular insulin infused over 60 minutes with 60 grams of glucose 1, 2
- This higher dose carries increased hypoglycemia risk without significant improvement in potassium reduction compared to the standard 10-unit dose 1
- The 20-unit regimen produces a mean potassium reduction of 0.79 mmol/L at 60 minutes, statistically equivalent to the 10-unit dose (P = 0.98) 2
Lower Dose Considerations
- Lower insulin doses (5 units) are not recommended as standard therapy due to reduced effectiveness in severe hyperkalemia 1
- The 5-unit dose produces 0.238 mmol/L less potassium reduction compared to 10 units in patients with K+ >6 mmol/L (P = 0.018) 3
- However, 5 units may be considered in high-risk populations for hypoglycemia, though this requires more frequent monitoring 4, 5
Pediatric Dosing
- For children, use weight-based dosing: 0.1 unit/kg of regular insulin IV with 400 mg/kg of glucose 1
- The insulin-to-glucose ratio for pediatric patients is 1 unit of insulin for every 4 grams of glucose, reflecting higher hypoglycemia risk 1
- Use D10W exclusively for pediatric patients 1
Glucose Administration Strategy
- D50W is standard for adults, but dilution to D25W is preferable when feasible 1
- For high-risk populations (low pretreatment glucose, no diabetes history, female gender, abnormal renal function, lower body weight), consider administering 50 grams of glucose instead of 25 grams with the standard 10-unit insulin dose 1, 5
- Never administer insulin without glucose, as this dramatically increases hypoglycemia risk 1
Critical Monitoring Requirements
- Monitor blood glucose hourly for at least 4-6 hours after insulin administration, as insulin's effect may exceed dextrose duration 1, 5
- Recheck potassium levels as the insulin effect wanes after 4-6 hours and rebound hyperkalemia can occur 1
- The onset of potassium-lowering effect begins at approximately 30 minutes, with peak effect at 60 minutes 6
Evidence Comparison: Bolus vs Infusion
- No statistically significant difference exists in potassium reduction between insulin administered as a bolus versus infusion 2
- Bolus administration of 10 units produces equivalent potassium reduction (0.78 mmol/L) compared to 20-unit infusion over 60 minutes (0.79 mmol/L, P = 0.98) 2
- Bolus administration is simpler and equally effective, making it the preferred method for emergency management 2
Hypoglycemia Risk Mitigation
- Almost one-fifth of patients experience hypoglycemia with insulin therapy for hyperkalemia 2
- Risk factors include low baseline glucose, no diabetes history, female sex, renal insufficiency, and lower body weight 5
- The 10-unit dose causes hypoglycemia in 19.5% of patients versus 9.2% with 5 units (P = 0.052), though this difference is not statistically significant 4
- Administer sufficient glucose: 60 grams with 20 units of insulin and 50 grams with 10 units to prevent hypoglycemia 2, 5
Common Pitfalls to Avoid
- Never administer insulin without concurrent glucose administration 1
- Do not rely on insulin alone—it is a temporizing measure that does not remove potassium from the body 1, 6
- Remember that definitive potassium removal strategies (dialysis, diuretics, potassium binders) must be implemented concurrently 1
- Avoid using lower insulin doses (5 units) in severe hyperkalemia (K+ >6 mmol/L) as they are less effective 3